Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) Return on Sales (2016 - 2025)

Historic Return on Sales for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to 0.28%.

  • Resmed's Return on Sales rose 100.0% to 0.28% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.28%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.27% for FY2025, which is 500.0% up from last year.
  • Resmed's Return on Sales amounted to 0.28% in Q4 2025, which was up 100.0% from 0.26% recorded in Q3 2025.
  • Resmed's 5-year Return on Sales high stood at 0.28% for Q1 2025, and its period low was 0.1% during Q1 2021.
  • Its 5-year average for Return on Sales is 0.22%, with a median of 0.22% in 2021.
  • As far as peak fluctuations go, Resmed's Return on Sales plummeted by -3100bps in 2021, and later skyrocketed by 3100bps in 2022.
  • Resmed's Return on Sales (Quarter) stood at 0.23% in 2021, then dropped by -3bps to 0.22% in 2022, then dropped by -17bps to 0.18% in 2023, then soared by 50bps to 0.27% in 2024, then increased by 3bps to 0.28% in 2025.
  • Its Return on Sales was 0.28% in Q4 2025, compared to 0.26% in Q3 2025 and 0.28% in Q2 2025.